Transaction #21423 · Form 4 · 0001140361-25-045906
Roivant Sciences Ltd. · Exercise / conversion · Common Shares
Roivant Sciences Ltd. · Transacted December 15, 2025 · Filed December 17, 2025
What does this filing report?
An SEC Form 4 filing for Roivant Sciences Ltd. records an exercise / conversion involving Common Shares on December 15, 2025. The reported quantity was 234,096. The filing date is December 17, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Roivant Sciences Ltd.
- Company CIK
- 0001635088
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 234,096
- Reported price
- 4.06
- Reference value
- 950,429.76
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 17,521,177
- Ownership description
- Not reported
- SEC acceptance time
- Dec 17, 2025, 9:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Gline Matthew ↗
CEO · Director
CIK 0001750094
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.
- F2
- Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.
- F3
- Award of stock options to purchase Common Shares that is fully vested.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.